PAVmed (PAVM) Shareholder's Equity (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.43% |
| Sep 30, 2025 | 15.49% |
| Jun 30, 2025 | -27.67% |
| Mar 31, 2025 | 1,660.40% |
| Jun 30, 2024 | 9.39% |
| Mar 31, 2024 | 14.34% |
| Dec 31, 2023 | -51.74% |
| Sep 30, 2023 | -1,806.99% |
| Jun 30, 2023 | -107.68% |
| Mar 31, 2023 | -1.19% |
| Dec 31, 2022 | -61.71% |
| Sep 30, 2022 | -31.03% |
| Jun 30, 2022 | -36.04% |
| Mar 31, 2022 | -18.49% |
| Dec 31, 2021 | 125.40% |
| Sep 30, 2021 | -16.19% |
| Jun 30, 2021 | -12.49% |
| Mar 31, 2021 | 10,256.45% |
| Dec 31, 2020 | 96.80% |
| Sep 30, 2020 | -15.28% |
| Jun 30, 2020 | 21.10% |
| Mar 31, 2020 | -249.91% |
| Dec 31, 2019 | -92.69% |
| Sep 30, 2019 | -28.10% |
| Jun 30, 2019 | 66.85% |
| Mar 31, 2019 | -128.92% |
| Dec 31, 2018 | -169.48% |
| Sep 30, 2018 | -45.36% |
| Jun 30, 2018 | 2,531.51% |
| Mar 31, 2018 | 108.70% |
| Dec 31, 2017 | 51.83% |
| Sep 30, 2017 | -17.10% |
| Jun 30, 2017 | -17.05% |
| Mar 31, 2017 | -1,252.22% |
| Dec 31, 2016 | -127.90% |
| Sep 30, 2016 | -58.40% |